West Pharmaceutical Services (WST) Current Leases (2019 - 2026)

West Pharmaceutical Services (WST) has reported Current Leases for 8 consecutive years, with $20.9 million the latest figure, recorded in Q2 2026.

• Quarterly Current Leases changed 0.0% year-over-year to $20.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $22.7 million, up 26.82% from the prior year.
• Current Leases declined to $20.9 million in Q2 2026 per WST's latest filing, from $21.4 million in the prior quarter.
• Over the last five years, Current Leases for WST reached as high as $22.7 million in Q4 2025 and fell as low as $9.8 million in Q1 2022.
• A 5-year average of $17.8 million and a median of $18.0 million in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases surged 72.04% — and 2026, when it slipped 1.83%.
• Year by year, Current Leases stood at $16.0 million in 2022, then increased by 10.62% to $17.7 million in 2023, then climbed by 1.13% to $17.9 million in 2024, then advanced by 26.82% to $22.7 million in 2025, then dropped by 7.93% to $20.9 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $20.9 million, $21.4 million, and $22.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.